Since GLP-1 is an incretin hormone playing an anti-diabetic role, GLP-1 increase after bariatric surgery has also been regarded as a central event in RYGB-induced remission of T2DM (Rhee et al., 2012). This evidence concerns the gene GCG and type 2 diabetes mellitus.